Type 2 Diabetes is a Common Condition that Causes High Blood Sugar (Glucose) Levels in Iraqi Patients with Some Parameters Measured
Abstract
Diabetes mellitus (T2DM) is a multifactorial disorder that is quickly expanding in all landmasses of the world, causing high glucose levels in patients. An example of 60 Iraqi patients with type 2 diabetes was explored in view of a few standards. The glycemic control standards included fasting blood glucose (FBG), glycated hemoglobin (HbA1C), and insulin levels. The serum uric analysis was incorporated. The consequences of the current review showed a huge increment (P˃0.05) in FBG, HbA1c, and insulin levels in type 2 diabetes patients contrasted with controls. Insulin responsiveness showed a huge decline (P˃0.05) in patients contrasted with controls. Uric corrosive levels expanded in type 2 diabetes patients, yet the distinctions were non-huge. TAC level had a huge reverse relationship (P˃0.05). HbA1c levels showed a critical opposite relationship (P˃0.05) with uric corrosive.
References
R. Goldenberg and Z. Punthakee, "Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome," Canadian Journal of Diabetes, vol. 37, pp. S8-S11, 2013.
American Diabetes Association, "Diagnosis and Classification of Diabetes Mellitus," Diabetes Care, vol. 33, suppl. 1, pp. S62-S69, 2010.
S. Ramya and G. Prasanna, "Biochemical Studies on Blood Sample of Diabetes Mellitus Patients," Journal of Chemical and Pharmaceutical Research, vol. 7, no. 6, pp. 22-26, 2015.
D. W. Cooke and L. Plotnick, "Type 1 Diabetes Mellitus in Pediatrics," Pediatrics in Review, vol. 29, no. 11, pp. 374-385, 2008.
A. Adesokan, O. I. Oyewole, and B. M. S. Turay, "Kidney and Liver Function Parameters in Alloxan-Induced Diabetic Rats Treated With Aloe Barbadensis Juice Extract," Sierra Leone Journal of Biomedical Research, vol. 1, no. 1, pp. 33-37, 2009.
G. Wilcox, "Insulin and Insulin Resistance," Clinical Biochemist Reviews, vol. 26, no. 2, pp. 19-25, 2005.
M. Taniguchi, B. Emanuelli, and C. R. Kahn, "Critical Nodes in Signalling Pathways: Insights Into Insulin Action," Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 85-96, 2006.
H. N. Ginsberg, "Insulin Resistance and Cardiovascular Disease," Journal of Clinical Investigation, vol. 106, no. 4, pp. 453-458, 2000.
S. Wild, G. Roglic, A. Green, R. Sicree, and H. King, "Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030," Diabetes Care, vol. 27, no. 5, pp. 1047-1053, 2004.
M. Muoio and C. B. Newgard, "Molecular and Metabolic Mechanisms of Insulin Resistance and β-Cell Failure in Type 2 Diabetes," Nature Reviews Molecular Cell Biology, vol. 9, no. 3, pp. 193-205, 2008.
O. T. Hardy, M. P. Czech, and S. Corvera, "What Causes the Insulin Resistance Underlying Obesity?" Current Opinion in Endocrinology, Diabetes and Obesity, vol. 19, no. 2, pp. 81-87, 2012.
T. Ota, "Obesity-Induced Inflammation and Insulin Resistance," Frontiers in Endocrinology, vol. 5, p. 204, 2014.
S. W. Coppack, "Pro-Inflammatory Cytokines and Adipose Tissue," Proceedings of the Nutrition Society, vol. 60, no. 3, pp. 349-356, 2001.
B. Vandanmagsar, Y. H. Youm, A. Ravussin, J. E. Galgani, K. Stadler, R. L. Mynatt, et al., "The NLRP3 Inflammasome Instigates Obesity-Induced Inflammation and Insulin Resistance," Nature Medicine, vol. 17, no. 2, pp. 179-188, 2011.
T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, et al., "Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing With Stress and Metabolic Homeostasis," Cell, vol. 140, no. 3, pp. 338-348, 2010.
J. F. Tanti, F. Ceppo, J. Jager, and F. Berthou, "Implication of Inflammatory Signaling Pathways in Obesity-Induced Insulin Resistance," Frontiers in Endocrinology, vol. 3, p. 181, 2013.
J. S. Orr, M. J. Puglisi, K. L. Ellacott, C. N. Lumeng, D. H. Wasserman, and A. H. Hasty, "Toll-Like Receptor 4 Deficiency Promotes the Alternative Activation of Adipose Tissue Macrophages," Diabetes, vol. 61, no. 11, pp. 2718-2727, 2012.
K. Rehman and M. S. H. Akash, "Mechanisms of Inflammatory Responses and Development of Insulin Resistance: How Are They Interlinked?" Journal of Biomedical Science, vol. 23, p. 1, 2016.
F. Zatterale, M. Longo, J. Naderi, G. A. Raciti, A. Desiderio, C. Miele, and F. Beguinot, "Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes," Frontiers in Physiology, vol. 19, p. 1607, 2020.
B. C. Martin, J. H. Warram, A. S. Krolewski, J. S. Soeldner, C. R. Kahn, and R. N. Bergman, "Role of Glucose and Insulin Resistance in Development of Type 2 Diabetes Mellitus: Results of a 25-Year Follow-Up Study," The Lancet, vol. 340, no. 8825, pp. 925-929, 1992.
I. F. Godsland, J. A. R. Jeffs, and D. G. Johnston, "Loss of Beta Cell Function as Fasting Glucose Increases in the Non-Diabetic Range," Diabetologia, vol. 47, pp. 1157-1166, 2004.
R. H. Unger, E. Aguilar-Parada, W. A. Müller, and A. M. Eisentraut, "Studies of Pancreatic Alpha Cell Function in Normal and Diabetic Subjects," Journal of Clinical Investigation, vol. 49, no. 4, pp. 837-848, 1970.
L. Page, J. B. Caulfield, J. A. Kastor, R. W. DeSanctis, and C. A. Sanders, "Myocardial Changes Associated With Cardiogenic Shock," New England Journal of Medicine, vol. 285, no. 3, pp. 133-137, 1971.
Copyright (c) 2024 Husam Hadi Jasim, Nagham Qasim Kadhim
This work is licensed under a Creative Commons Attribution 4.0 International License.
